The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week ...

The stock's fall snapped a three-day winning streak.

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.

Chairman and CEO of Abbott Laboratories (NYSE:ABT), recently sold a significant portion of his holdings in the company. According to a Form 4 filing with the Securities and Exchange Commission, Ford ...

His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...

The company has a market cap of $222.36 billion ... 75.18% of the stock is owned by institutional investors. Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures ...

The firm has a market cap of $222.36 billion ... In other news, EVP Daniel Gesua Sive Salvadori sold 23,771 shares of Abbott Laboratories stock in a transaction on Thursday, January 30th.

Stocks such as Natco, Dr. Reddy's, Cipla, Mankind, Torrent, Sun Pharma, Abbott, and Glenmark slipped in the range of 1-2 per ...